Loading…
Orthofix Medical Inc. is projected to rise to $9.48 by 2027, a +2% move from its current price of $9.32. OFIX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.06 | $9.32 | $9.59 | 0.00% |
| May 30 | $8.96 | $9.32 | $9.70 | +0.01% |
| May 31 | $8.88 | $9.32 | $9.79 | +0.01% |
| Jun 1 | $8.81 | $9.32 | $9.86 | +0.02% |
| Jun 2 | $8.75 | $9.32 | $9.93 | +0.02% |
| Jun 3 | $8.70 | $9.32 | $9.99 | +0.03% |
| Jun 4 | $8.66 | $9.32 | $10.04 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.66 | $9.32 | $10.04 | +0.03% |
| Week 2 | $8.40 | $9.33 | $10.36 | +0.07% |
| Week 3 | $8.20 | $9.33 | $10.61 | +0.10% |
| Week 4 | $8.04 | $9.33 | $10.83 | +0.14% |
| Week 5 | $7.91 | $9.34 | $11.02 | +0.17% |
| Week 6 | $7.79 | $9.34 | $11.20 | +0.21% |
| Week 7 | $7.68 | $9.34 | $11.37 | +0.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Orthofix Medical Inc. is a healthcare company that operates as a medical technology business in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation.
This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V.
and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Orthofix Medical Inc. trades in the healthcare space as a medical technology company. It currently changes hands at $9.77 per share and has a market capitalization of $394.92M, with a market rank of 3240.
The latest price environment sits alongside a mixed near-term technical view and an extensive long-range forecast that envisions a rising price path through 2030 and beyond. The near-term forecast places values near the current level, while the long-range projections show substantial upside potential by the end of the forecast window.
A major floor 25.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 38.1% above — a clean break opens room to run.
A major ceiling 50.8% above — clearing it would confirm fresh momentum.
Key OFIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OFIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.48 | Sell | $10.29 | Sell |
| MA 10 | $11.31 | Sell | $10.91 | Sell |
| MA 20 | $11.63 | Sell | $11.41 | Sell |
| MA 50 | $11.88 | Sell | $11.95 | Sell |
| MA 100 | $12.71 | Sell | $12.57 | Sell |
| MA 200 | $13.86 | Sell | $13.26 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 25.81 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -240.63 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.28 | Sell |
| ROC (12) | -20.00 | Sell |
| Bollinger %B (20,2) | -0.18 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.23 | Sell |
| Awesome (5,34) | -1.47 | Sell |
| Ultimate (7,14,28) | 19.04 | Buy |
| Momentum (10) | -2.86 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 9.50 | Sell |
| ADX (14) | 16.88 | Neutral |
| ATR (14) | 0.36 | Info |
The near-term technical picture shows neutral sentiment with RSI(14) at 30. The stock trades around support at $9.77 and faces resistance at $12.87. The 30-day range runs from $8.16 to $11.69, indicating a relatively tight trading band near the current price.
The stock exhibits elevated volatility, with annualized volatility at 50%, underscoring the potential for outsized moves within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.32 | $9.32 | $11.85 | 0% | Neutral | |
| $7.50 | $9.48 | $12.71 | +2% | Neutral | |
| $8.33 | $10.84 | $15.07 | +16% | Neutral | |
| $9.82 | $13.07 | $18.70 | +40% | Bullish | |
| $9.63 | $13.09 | $19.20 | +40% | Bullish | |
| $10.23 | $14.16 | $21.23 | +52% | Bullish | |
| $10.37 | $14.63 | $22.34 | +57% | Bullish | |
| $9.32 | $13.37 | $20.78 | +43% | Bullish | |
| $10.71 | $15.60 | $24.63 | +67% | Bullish | |
| $12.62 | $18.67 | $29.93 | +100% | Bullish | |
| $14.39 | $22.82 | $38.94 | +145% | Bullish | |
| $25.76 | $46.05 | $86.10 | +394% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $9.32 | $9.32 | $10.93 | +0.00% |
| June 2026 | $7.81 | $9.17 | $11.04 | -1.56% |
| July 2026 | $7.90 | $9.36 | $11.42 | +2.04% |
| August 2026 | $7.98 | $9.52 | $11.74 | +1.69% |
| September 2026 | $7.69 | $9.23 | $11.48 | -3.04% |
| October 2026 | $7.51 | $9.06 | $11.35 | -1.90% |
| November 2026 | $7.67 | $9.29 | $11.73 | +2.62% |
| December 2026 | $7.66 | $9.33 | $11.85 | +0.36% |
Click any year to see its month-by-month OFIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OFIX could reach as high as $11.85, with a base case around $9.32 and support toward $9.32 — roughly 0% from $9.32. A consolidation phase looks the most probable path here.
Expect OFIX to range from $7.50 to $12.71 through 2027. The $9.48 average target implies a +2% move from current prices. That is up +2% on the projected 2026 average. Price action looks broadly range-bound.
The OFIX price prediction for 2028 points to an average of $10.84 (low $8.33, high $15.07) — a potential gain of +16% on today's $9.32. A consolidation phase looks the most probable path here.
In 2029, OFIX is projected to trade between $9.82 and $18.70, averaging $13.07 — a potential gain of +40% from today's $9.32. That is up +21% on the projected 2028 average. Momentum favours further upside here.
Orthofix Medical Inc.'s 2030 outlook centres on $13.09, within a $9.63 to $19.20 range. That is up 0% on the projected 2029 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, OFIX could reach as high as $21.23, with a base case around $14.16 and support toward $10.23 — roughly +52% from $9.32. Momentum favours further upside here.
Expect OFIX to range from $10.37 to $22.34 through 2032. The $14.63 average target implies a +57% move from current prices. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The OFIX price prediction for 2033 points to an average of $13.37 (low $9.32, high $20.78) — a potential gain of +43% on today's $9.32. Momentum favours further upside here.
In 2034, OFIX is projected to trade between $10.71 and $24.63, averaging $15.60 — a potential gain of +67% from today's $9.32. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Orthofix Medical Inc.'s 2035 outlook centres on $18.67, within a $12.62 to $29.93 range. That is up +20% on the projected 2034 average. That marks a +100% change versus current levels. Momentum favours further upside here.
By 2040, OFIX could reach as high as $38.94, with a base case around $22.82 and support toward $14.39 — roughly +145% from $9.32. Buyers look set to stay in control over this stretch.
Expect OFIX to range from $25.76 to $86.10 through 2050. The $46.05 average target implies a +394% move from current prices. That is up +102% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OFIX today (≈ 107.296137 OFIX) could be worth
$4,940.79
+$3,940.79 (+394%) by 2050 · US Dollar
Based on the average projected OFIX price of $46.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OFIXwould be worth at today's price.
$1,000 invested in OFIX on May 27, 2025 (≈ 87.032204 OFIX) would be worth
$811.14
-$188.86 (-18.9%) today · 0.81× · US Dollar
Based on a OFIX entry price of $11.49 vs. today's $9.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12.15 | $767.08 | -23.3% |
| 1 month ago | $12.32 | $756.49 | -24.4% |
| 3 months ago | $13.17 | $707.67 | -29.2% |
| 6 months ago | $16.09 | $579.24 | -42.1% |
| 1 year ago | $11.49 | $811.14 | -18.9% |
| All time (5.0y) ago | $41.77 | $223.13 | -77.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OFIX forecast.
Our base-case forecast reaches $19.00 around 2040.
Implied market cap at $19.00: $768.01M
The multi-year forecast points to a bullish trajectory, with the 2029 average price at $14.00 and 2030 average at $14.08, both delivering strong upside given the current price. The 2031 average reaches $15.29, 2032 at $15.83, and 2034 at $17.16, with 2035 averaging $20.52 and a 110% ROI. The forecast then suggests a continuation of gains through 2040 at an average of $25.33 and a 159.2% ROI, culminating in 2050 with an average of $51.16 and a 423.6% ROI.
These are estimates, not guarantees, and depend on market conditions, product uptake, and broader healthcare dynamics. The sentiment remains bullish across the long horizon, but risk factors and uncertainties may affect realized results.
Tap a question to reveal the answer.
2030 average price is $14.08, with a min of $10.42 and a max of $20.52, yielding a 44.1% ROI and a bullish sentiment.
Forecasts show a bullish path through 2030 with 2030 average at $14.08 and 2050 average at $51.16, yielding a 44.1% ROI in 2030 and 423.6% ROI in 2050; these are estimates and not guarantees.
The 2050 forecast lists an average of $51.16 and a max of $94.55 with a 423.6% ROI, indicating potential long-term upside to around the $50 level, subject to uncertainty.
Current price is $9.77 and market cap is $394.92M.
RSI(14) is 30, with a 30-day range of $8.16–$11.69; price sits near support at $9.77 and facing resistance at $12.87; annualized volatility is 50%.
Orthofix Medical Inc. Community Discussion
0Share your Orthofix Medical Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.